NDC 50090-1242

RESTASIS

Cyclosporine

RESTASIS is a Ophthalmic Emulsion in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Cyclosporine.

Product ID50090-1242_2af9d19d-a029-4d25-9d01-99e7caf324a8
NDC50090-1242
Product TypeHuman Prescription Drug
Proprietary NameRESTASIS
Generic NameCyclosporine
Dosage FormEmulsion
Route of AdministrationOPHTHALMIC
Marketing Start Date2003-04-01
Marketing CategoryNDA / NDA
Application NumberNDA050790
Labeler NameA-S Medication Solutions
Substance NameCYCLOSPORINE
Active Ingredient Strength1 mg/mL
Pharm ClassesCalcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 50090-1242-0

30 VIAL, SINGLE-USE in 1 TRAY (50090-1242-0) > .4 mL in 1 VIAL, SINGLE-USE
Marketing Start Date2014-11-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50090-1242-0 [50090124200]

RESTASIS EMULSION
Marketing CategoryNDA
Application NumberNDA050790
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28
Inactivation Date2020-01-31
Reactivation Date2020-02-14

Drug Details

Active Ingredients

IngredientStrength
CYCLOSPORINE.5 mg/mL

OpenFDA Data

SPL SET ID:ce9325ab-fca1-4dae-8e53-a46ec95d3a76
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 402092
  • 351291
  • Pharmacological Class

    • Calcineurin Inhibitor Immunosuppressant [EPC]
    • Calcineurin Inhibitors [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • P-Glycoprotein Inhibitors [MoA]

    NDC Crossover Matching brand name "RESTASIS" or generic name "Cyclosporine"

    NDCBrand NameGeneric Name
    0023-9163RESTASIScyclosporine
    50090-1242RESTASISRESTASIS
    50090-4476RESTASISRESTASIS
    0074-3108GengrafCyclosporine
    0074-3109GengrafCyclosporine
    0074-7269GengrafCyclosporine
    0078-0246Neoralcyclosporine
    0078-0248Neoralcyclosporine
    0023-5301Restasis MultiDosecyclosporine
    0078-0109Sandimmunecyclosporine
    0078-0110Sandimmunecyclosporine
    0078-0240Sandimmunecyclosporine
    0078-0241Sandimmunecyclosporine

    Trademark Results [RESTASIS]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    RESTASIS
    RESTASIS
    78054981 2748674 Live/Registered
    ALLERGAN, INC.
    2001-03-26
    RESTASIS
    RESTASIS
    78041554 2738873 Live/Registered
    Allergan, Inc.
    2001-01-03
    RESTASIS
    RESTASIS
    75409897 not registered Dead/Abandoned
    ALLERGAN ELITE, INC.
    1997-12-23

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.